Dr. Douglas Scott Richardson, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 21495 Ridgetop Cir, Suite 204, Sterling, VA 20166 Phone: 703-439-3939 Fax: 703-430-5529 |
Sonia Mikhail Kheir, MD Dermatology - Dermatopathology Medicare: Medicare Enrolled Practice Location: 405 Glenn Dr, Ste 10a, Sterling, VA 20164 Phone: 703-404-8189 Fax: 703-404-1131 |
Stephanie Y. Daniel, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 22365 Broderick Drive, Suite 115, Sterling, VA 20166 Phone: 703-996-4000 Fax: 571-707-8123 |
Dr. Blake Reid Zelickson, M.D., PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 22365 Broderick Drive, Suite 115, Sterling, VA 20166 Phone: 170-399-6400 Fax: 571-707-8123 |
Anjali D Chandela, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 14 Pidgeon Hill Dr, Suite 340, Sterling, VA 20165 Phone: 703-450-5959 |
News Archive
The world's first international study on homophobia in sport, "Out on the Fields," has found widespread homophobia in UK sport, prompting calls for a zero tolerance approach towards discrimination and better training for coaches, teachers and officials.
CME Medical, the UK's fastest growing specialist infusion company, has launched a new online mobile phone app for users of the company's T34TM Ambulatory Syringe Pump . The app demonstrates the company's commitment to developing accessible education programmes for all of its customers. It incorporates information which is also available in printed Quick User Guides and helps people through the process of using the pump. The app can be used on any device with an internet connection.
Acute lymphoblastic leukemia (ALL) leukemia is the most common type of cancer in children. It can occur in various forms, differing not only by specific changes in the genetic material of the leukemia cells but also by their response to therapies. Now, an international team of scientists from Berlin, Düsseldorf, Hannover, Heidelberg, Kiel, and Zurich have succeeded in decoding the molecular characteristics of an as yet incurable subtype of leukemia, paving the way for new therapeutic approaches.
"Results of a major HIV prevention trial suggest that daily use of a product - whether a vaginal gel or an oral tablet - does not appear to be the right approach for preventing HIV in young, unmarried African women," a press release from the Microbicide Trials Network reports.
› Verified 1 days ago